EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein, Nucleic Acid, and Nanomaterial Engineering for Biosensors and Monitoring

Milica Crnoglavac Popović iD, Vesna Stanković iD, Dalibor Stanković iD, Radivoje Prodanović iD

Biosensors · 2025

DOI: 10.3390/bios15070430 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Milica Crnoglavac Popović und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Belgrade, Studentski trg 12, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Biosensing Techniques, Nanostructures, Nucleic Acids, Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Ministry of Science, Technological Development, and Innovation of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The engineering of proteins, nucleic acids, and nanomaterials has significantly advanced the development of biosensors for the monitoring of rare diseases. These innovative biosensing technologies facilitate the early detection and management of conditions that often lack adequate diagnostic solutions. By utilizing engineered proteins and functional nucleic acids, such as aptamers and nucleic acid sensors, these biosensors can achieve high specificity in identifying the biomarkers associated with rare diseases. The incorporation of nanomaterials, like nanoparticles and nanosensors, enhances sensitivity and allows for the real-time monitoring of biochemical changes, which is critical for timely intervention. Moreover, integrating these technologies into wearable devices provides patients and healthcare providers with continuous monitoring capabilities, transforming the landscape of healthcare for rare diseases. The ability to detect low-abundance biomarkers in varied sample types, such as blood or saliva, can lead to breakthroughs in understanding disease pathways and personalizing treatment strategies. As the field continues to evolve, the combination of protein, nucleic acid, and nanomaterial engineering will play a crucial role in developing next-generation biosensors that are not only cost-effective but also easy to use, ultimately improving outcomes and the quality of life for individuals affected by rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNanostructuresNucleic AcidsProteinsHumans

Stichwörter der Autor:innen

DNAMOFRNAbiosensordirected evolutionnanocompositesrare diseases

Substanzen

Nucleic AcidsProteins

Autor:innen und Institutionen

  • Faculty of Chemistry, University of Belgrade, Studentski trg 12, 11000 Belgrade, Serbia.
  • IHTM, Njegoševa 12, 11000 Belgrade, Serbia.

ORCID-Profile: Milica Crnoglavac Popović, Vesna Stanković, Dalibor Stanković, Radivoje Prodanović

Förderung

  • Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • Ministry of Science, Technological Development, and Innovation of the Republic of Serbia

Zitieren

APA

Crnoglavac Popović, M., Stanković, V., Stanković, D., & Prodanović, R. (2025). Protein, Nucleic Acid, and Nanomaterial Engineering for Biosensors and Monitoring. Biosensors. https://doi.org/10.3390/bios15070430

Vancouver

Crnoglavac Popović M, Stanković V, Stanković D, Prodanović R. Protein, Nucleic Acid, and Nanomaterial Engineering for Biosensors and Monitoring. Biosensors. 2025. doi:10.3390/bios15070430

BibTeX
@article{CrnoglavacPopovi2025,
  author = {Crnoglavac Popović, Milica and Stanković, Vesna and Stanković, Dalibor and Prodanović, Radivoje},
  title = {Protein, Nucleic Acid, and Nanomaterial Engineering for Biosensors and Monitoring},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15070430}
}
Kostenlos starten →